RARB and small cell lung carcinoma: The restoration of the lost expression of RARβ in the H209 SCLC cells and treatment with 1 μM of ATRA led to the growth inhibition, and this was accompanied by increased expression of the CDK inhibitor p27KipI, decreased L-myc expression, and reduced CDK-2 activity [153].